Can Pharmacological Targeting of Advanced Glycation End Products Provide Protection Against Experimentally Induced Liver Fibrosis?

Baraka AM^* and Guemei A

Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Egypt

^*Corresponding Author: Baraka AM, Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, 00201224568012, Egypt Email: